Source: BUSINESS WIRE

Press Release: Gene Signal : Research and Markets: Global Retinopathy Of Prematurity Therapeutics Pipeline Review, H2 2014 - Analysis of 6 Companies & 8 Drug Profiles

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/zq3fdl/retinopathy_of) has announced the addition of the "Retinopathy Of Prematurity - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Retinopathy Of Prematurity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molec

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Eric Viaud's photo - Co-Founder & CEO of Gene Signal

Co-Founder & CEO

Eric Viaud

CEO Approval Rating

81/100

Read more